share_log

HC Wainwright & Co. Reiterates Buy on Enlivex Therapeutics, Maintains $7 Price Target

Moomoo 24/7 ·  Apr 23 06:33

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Enlivex Therapeutics (NASDAQ:ENLV) with a Buy and maintains $7 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment